Advertisement

Topics

Puma Biotechnology, Inc. Company Profile

12:15 EST 13th February 2016 | BioPortfolio

Puma Biotechnology, Inc. is a development stage biopharmaceutical company that acquires and develops innovative products for the treatment of various forms of cancer. The Company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seeks to further develop those drug candidates for commercial use. The Company is initially focused on the development of PB-272 (oral neratinib), a potent irreversible tyrosine kinase inhibitor, for the treatment of patients with HER2 positive metastatic breast cancer.


News Articles [209 Associated News Articles listed on BioPortfolio]

Data Takes A Bite Out of Puma Shares

Puma Biotechnology added to its portfolio of clinical data for its once-potential blockbuster neratinib at the San Antonio Breast Cancer Symposium on Dec. 10, but the positive new Phase II data still ...

Puma Continues Long Post-ASCO Plunge On Latest Data

Puma Biotechnology Inc.'s data for the tyrosine kinase inhibitor neratinib (PB272) in the treatment of breast cancer now seem to disappoint investors every time the Los Angeles-based company reports r...

Puma Biotechnology: Neritanib Is Being Misunderstood

Puma Biotechnology: Neratinib Is Being Misunderstood

Puma slips on new neratinib data

Puma Biotechnology Inc. (NYSE:PBY) shed $4.28 to $67.94 on Friday after presenting data showing neratinib (PB272) led to a modest three-year disease-free survival (DFS) benefit as an adjuvant treatmen...

Biotech Weekly: Stories To Track Into SABCS, Oncothyreon And Puma Biotechnology

Puma Biotechnology to Present at Credit Suisse Healthcare Conference

Puma Biotechnology, Inc. (NYSE: PBYI), a development stage biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of ...

Puma Biotechnology to Participate in Fireside Chat at Leerink Partners Global Healthcare Conference

Puma Biotechnology, Inc. (NYSE: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will partici...

Drugs and Medications [3 Associated Drugs and Medications listed on BioPortfolio]

Korres quercetin 7 oak hydrating antiageing and antiwrinkle [Johnson & Johnson Consumer Products Company, Division of Johnson & Johnson Consumer Companies, Inc.]

Korres Quercetin & Oak Day Cream for Normal to Dry Skin SPF 4

Bio-active anti-aging [S.I.P.R.E.S. SRL]

Bio-Active Anti-Aging Cream Multi-Protection Daily Renewal SPF 15 Advanced Double Lifting Effect

Biodynamic skin [S.I.P.R.E.S. SRL]

Biodynamic Skin Solution

PubMed Articles [411 Associated PubMed Articles listed on BioPortfolio]

PUMA gene transfection can enhance the sensitivity of epirubicin-induced apoptosis of MCF-7 breast cancer cells.

We explored whether p53 upregulated modulator of apoptosis (PUMA) gene transfection could enhance the sensitivity of epirubicin-induced apoptosis of MCF-7 breast cancer cells. The liposome-mediated re...

Role of PUMA in methamphetamine-induced neuronal apoptosis.

Exposure to methamphetamine (METH), a widely used illicit drug, has been shown to cause neuron apoptosis. p53 upregulated modulator of apoptosis (PUMA) is a key mediator in neuronal apoptosis. This st...

Uncoupling of PUMA Expression and Apoptosis Contributes to Functional Heterogeneity in Renal Cell Carcinoma - Prognostic and Translational Implications.

Renal cell carcinoma (RCC) is characterized by a profound disruption of proapoptotic signaling networks leading to chemo- and radioresistance. A key mediator of DNA damage-induced apoptosis is the BH3...

Phylogenetically Distant Viruses Use the Same BH3-Only Protein Puma to Trigger Bax/Bak-Dependent Apoptosis of Infected Mouse and Human Cells.

Viruses can trigger apoptosis of infected host cells if not counteracted by cellular or viral anti-apoptotic proteins. These protective proteins either inhibit the activation of caspases or they act a...

Quantification of Unmethylated Alu (QUAlu): a tool to assess global hypomethylation in routine clinical samples.

Hypomethylation of DNA is a hallmark of cancer and its analysis as tumor biomarker has been proposed, but its determination in clinical settings is hampered by lack of standardized methodologies. Here...

Clinical Trials [5 Associated Clinical Trials listed on BioPortfolio]

A Pilot Scheme - Specimen Collection of Health Management Center

Biomedical and biotechnology industry is internationally regarded as the most brilliant star performer of the future. The development of biomedical depends on a high quality academic resea...

A Phase III Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants

In order to evaluate immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine produced by Beijing Minhai Biotechnology Co., Ltd., a randomized, double-blind, parallel-contro...

A Safety, Pharmacokinetic and Pharmacodynamic Study of Kevetrin in Patients With Advanced Solid Tumors

In the laboratory, Kevetrin activates p53, a tumor suppressor protein that has an important role in protecting the body. p53 functions by activating proteins that repair DNA and kill cells...

Dose Escalation Study to Evaluate Oral Rotavirus Vaccine 116E Live Attenuated in Healthy Infants 8 to 20 Weeks Old

This study will be a Phase I, randomized, double blind, safety and immunogenicity trial of the Vero cell based 116E neonatal rotavirus vaccine candidate strain in healthy non-malnourished ...

Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer

Unfortunately, despite the best clinical efforts and breakthroughs in biotechnology, most patients diagnosed with pancreatic cancer continue to die from the rapid progression of their dise...

Companies [872 Associated Companies listed on BioPortfolio]

Puma Biotechnology, Inc.

Puma Biotechnology, Inc. is a development stage biopharmaceutical company that acquires and develops innovative products for the treatment of various forms of cancer. The Company ...

PUMA

Task Group Public Perceptions of Biotechnology

The Task Group on Public Perceptions of Biotechnology is one of the six Task Groups of the European Federation of Biotechnology. It was established in 1991, to increase public awareness and understand...

Missouri Biotechnology Association

The Missouri Biotechnology Association is focused on maintaining the growth of the biotechnology industry generated by the research and development communities of Missouri. While we have made great st...

Swiss Biotech Association (SBA)

The Swiss Biotech Association (SBA) is the national association representing biotechnology companies, academic institutions, regional biotechnology centres and related organisations throughout Switzer...

More Information about "Puma Biotechnology, Inc." on BioPortfolio

We have published hundreds of Puma Biotechnology, Inc. news stories on BioPortfolio along with dozens of Puma Biotechnology, Inc. Clinical Trials and PubMed Articles about Puma Biotechnology, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Puma Biotechnology, Inc. Companies in our database. You can also find out about relevant Puma Biotechnology, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record